Intervention Review

Flupenthixol versus placebo for schizophrenia

  1. Xiaohong Shen1,*,
  2. Jun Xia2,
  3. Clive E Adams2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 12 AUG 2011

DOI: 10.1002/14651858.CD009777.pub2


How to Cite

Shen X, Xia J, Adams CE. Flupenthixol versus placebo for schizophrenia. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD009777. DOI: 10.1002/14651858.CD009777.pub2.

Author Information

  1. 1

    Shanghai University of Traditional Chinese Medicine, Shanghai Shuguang Hospital, Shanghai, China

  2. 2

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

*Xiaohong Shen, Shanghai Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. stalashen@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Magdolna Tardy, Markus Dold, Rolf R Engel, Stefan Leucht, Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia, The Cochrane Library,